[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342035-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342035-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","fmrp-protects-breast-cancer-cells-from-ferroptosis-by-promoting-slc7a11-alternative-splicing-through-interacting-with-hnrnpm","FMRP protects breast cancer cells from ferroptosis by promoting SLC7A11 alternative splicing through interacting with hnRNPM","","Ferroptosis is an iron-dependent form of regulated cell death driven by phospholipid peroxidation, and its control in breast cancer remains incompletely understood. This study finds that FMRP expression is elevated in breast cancer patients and correlates with poor prognosis and advanced pathological stage. FMRP overexpression induces ferroptosis resistance by upregulating SLC7A11, with mechanistic links to m6A RNA modification via METTL3 and translational regulation. FMRP also interacts with the splicing factor hnRNPM to modulate SLC7A11 exon-skip splicing. The resulting SLC7A11-S variant enhances ferroptosis resistance, and clinical analyses show increased FMRP/hnRNPM/SLC7A11 expression in tumors, aligning with worse survival. Targeting the FMRP–SLC7A11 axis may suppress ferroptosis resistance and tumor growth.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/fmrp-protects-breast-cancer-cells-from-ferroptosis-by-promoting-slc7a11-alternative-splicing-through-interacting-with-hnrnpm/342035/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/fmrp-protects-breast-cancer-cells-from-ferroptosis-by-promoting-slc7a11-alternative-splicing-through-interacting-with-hnrnpm/342035.png","ImageObject",300,407,{"name":42,"@type":43},"Skyler","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does FMRP influence ferroptosis in breast cancer cells?","Question",{"text":63,"@type":64},"FMRP overexpression promotes ferroptosis resistance by positively regulating the ferroptosis defense gene SLC7A11, thereby protecting breast cancer cells from ferroptosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does m6A modification play in the mechanism?",{"text":68,"@type":64},"Upregulated FMRP catalyzes m6A modification of SLC7A11 mRNA in a METTL3-dependent manner, and this subsequently affects SLC7A11 translation.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is hnRNPM important in regulating SLC7A11 splicing?",{"text":72,"@type":64},"FMRP interacts with the splicing factor hnRNPM to recognize the splice site, leading to modulation of an exon-skip splicing event in SLC7A11 transcripts.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342035,1790185807,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Redox Biology 77 (2024) 103382  \nContents lists available at ScienceDirect  \nRedox Biology  \njournal [homepage:](homepage: www.elsevier.com/locate/redox)[ www.elsevier.com/locate/redox](homepage: www.elsevier.com/locate/redox)  \n| FMRP protects breast cancer cells from ferroptosis by promoting SLC7A11 alternative splicing through interacting with hnRNPM\u003Cbr>Nan Wang a,b, Bin Shi c, Lu Dinga, Xu Zhang a, Xiaolan Maa,b, Songlin Guo a, Xia Qiao a, Libin Wang d,**, Duan Mae,***, Jia Cao a,*\u003Cbr>a Department of Surgery Laboratory, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, China b Department of Medical Oncology, General Hospital of Ningxia Medical University, Yinchuan, China\u003Cbr>c Department of Emergency, General Hospital of Ningxia Medical University, Yinchuan, China\u003Cbr>d Department of Neurosurgery, Huazhong University of Science and Technology Union Shenzhen Hospital/Shenzhen Nanshan Hospital, Shenzhen, China e Department of Biochemistry and Molecular Biology, Key Laboratory of Metabolism and Molecular Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, China |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords:\u003Cbr>FMRP Ferroptosis\u003Cbr>M6A modification SLC7A11\u003Cbr>Alternative splicing |  | Ferroptosis is a unique modality of regulated cell death that is driven by iron-dependent phospholipid peroxidation. N6-methyladenosine (m6A) RNA modification participates in varieties of cellular processes. However, it remains elusive whether m6A reader Fragile X Mental Retardation Protein (FMRP) are involved in the modulation of ferroptosis in breast cancer (BC). In this study, we found that FMRP expression was elevated and associated with poor prognosis and pathological stage in BC patients. Overexpression of FMRP induced ferroptosis resistance and exerted oncogenic roles by positively regulating a critical ferroptosis defense gene SLC7A11. Mechanistically, upregulated FMRP catalyzes m6A modification of SLC7A11 mRNA and further influences the SLC7A11 translation through METTL3-dependent manner. Further studies revealed that FMRP interacts with splicing factor hnRNPM to recognize the splice site and then modulated the exon skip splicing event of SLC7A11 transcript. Interestingly, SLC7A11-S splicing variant can effectively promote FMRP overexpression-induced ferroptosis resistance in BC cells. Moreover, our clinical data suggested that FMRP/hnRNPM/SLC7A11 expression were significantly increased in the tumor tissues, and this signal axis was important evaluation factors closely related to the worse survival and prognosis of BC patients. Overall, our results uncovered a novel regulatory mechanism by which high FMRP expression protects BC cells from undergoing ferroptosis. Targeting the FMRP–SLC7A11 axis has a dual effect of inhibiting ferroptosis resistance and tumor growth, which could be a promising therapeutic target for treating BC. |\n\n1. Introduction  \nBreast cancer (BC) is the most common malignant tumor among women worldwide and has increasing morbidity and mortality rates. Currently, surgical resection, chemoradiotherapy, endocrine therapy and targeted therapy have been applied in clinical practice. However, these treatment measures still cannot ideally reduce the recurrence and metastasis of BC [1]. It is easy to develop apoptosis resistance of cancer cells during BC treatment [2]. Therefore, identification of therapeutic targets with high sensitivity and specificity to break through the  \nlimitations of traditional anti-apoptotic mechanisms is of great significance for improving prognosis of BC patients.  \nFerroptosis is a unique modality of regulated cell death that distincts from apoptosis, necrosis and autophagy. The important hallmark offerroptosis is the imbalance of redox states with increased levels of intracellular toxic lipid peroxides [3]. Recent study has indicated that member 11 of the solute carrier family 7 (SLC7A11), a main func","cbCaibbjfwjCeVo1","https://ap.wps.com/l/cbCaibbjfwjCeVo1","pdf",21231724,17,"English","# Introduction\n## Background on breast cancer therapies\n## Ferroptosis and the SLC7A11/GPX4 axis\n## Rationale and study objective","[{\"question\":\"How does FMRP influence ferroptosis in breast cancer cells?\",\"answer\":\"FMRP overexpression promotes ferroptosis resistance by positively regulating the ferroptosis defense gene SLC7A11, thereby protecting breast cancer cells from ferroptosis.\"},{\"question\":\"What role does m6A modification play in the mechanism?\",\"answer\":\"Upregulated FMRP catalyzes m6A modification of SLC7A11 mRNA in a METTL3-dependent manner, and this subsequently affects SLC7A11 translation.\"},{\"question\":\"Why is hnRNPM important in regulating SLC7A11 splicing?\",\"answer\":\"FMRP interacts with the splicing factor hnRNPM to recognize the splice site, leading to modulation of an exon-skip splicing event in SLC7A11 transcripts.\"}]","FMRP protects breast cancer cells from ferroptosis by promoting SLC7A11 alternative splicing through interacting with hnRNPM | PDF",1790044855,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95d8c27b429b2a5be3e74862448c6fe2.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7001824f1fbdf78062338aed7bf1e486.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a05ce97fb3768b483d33cdeb41e53e1.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a12dd4a538b8a9e3f9ad24b7ee3f604e.webp",980,1306]